Without approval by the U.S. Food and Drug Administration, a new medical device called UVLrx has hit alternative medicine practices across the country. The device delivers an illuminated cocktail of red, green and ultraviolet wavelengths directly into the bloodstream that is claimed to improve circulation and oxygen saturation, reduce pain, modulate the immune system and lessen inflammation.
Research with the device is supposedly underway in Cameroon to treat HIV/AIDS, in Egypt for hepatitis C and in the Philippines for Dengue Fever. Paul LeMert, the managing director of UVLrx Therapeutics, stated last year in MedCity News that additional clinical trials for a number of conditions, including Lyme disease, were also underway in the Netherlands, Hong Kong and the United States.
